Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Raphael Pharmaceutical Inc. (RAPH) had Earnings per Share (EPS) (Basic) of $-0.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.26M |
|
-- |
|
-- |
|
$0.25M |
|
$-0.25M |
|
$0.00M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
19.63M |
|
19.63M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.01 |
$-0.01 |
|
| Balance Sheet Financials | |
$0.01M |
|
$0.00M |
|
$0.00M |
|
$0.01M |
|
$1.27M |
|
-- |
|
-- |
|
$1.27M |
|
$-1.26M |
|
$-1.26M |
|
$-1.26M |
|
19.63M |
|
| Cash Flow Statement Financials | |
$-0.26M |
|
-- |
|
$0.24M |
|
$0.02M |
|
$0.00M |
|
$-0.02M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.26M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
19.54% |
|
19.54% |
|
-3528.57% |
|
19.54% |
|
$-0.06 |
|
$-0.01 |
|
$-0.01 |
|